While studies in non-IBD patients have implicated T cell responses and cytokines such as IL-33 to be associated with asymptomatic infection and the convalescent phase of SARS-CoV-2 infection, to our knowledge this is the first study to similarly interrogate cytokine expression in patients with IBD8–10. Here, IL33 is linked to inflammatory bowel disease.